Frank Ognibene
Foot & Ankle Surgery · Memphis, TNNPI 1649275058
Payments from drug & device makers
What this record shows
This record is dominated by other: $147,277 of the $147,974 with a category attached, or 99.5%. Linvatec Corporation accounts for 99.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $129,873 and has fallen 97.4% since, to $3,365 in 2024. Among foot & ankle surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $7788.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$147K
- Amgen$316
- Smith+Nephew$132
- Stryker$109
- Treace Medical Concepts, Inc.$83
- Sandoz$25
- plus $33 from 2 others
Across 9 payments — averaging $22,792 each. An ownership or investment interest held by the physician or an immediate family member.
- Somavac Medical Solutions, Inc.$205K
- Crossroads Extremity Systems, LLC$0
What the payments were for
- Food & beverage$6980%
- Other$147,277100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 5 | $147,277 |
| Amgen | 7 | $316 |
| Smith+Nephew | 2 | $132 |
| Stryker | 1 | $109 |
| Treace Medical Concepts, Inc. | 1 | $83 |
| Sandoz | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$147,277
- REGRANEX$116
- CARTIVA$109
- KRYSTEXXA$103
How this compares
$147,974 in reported general payments places this provider in the 95th percentile of 145 foot & ankle surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 96 | $3,001 |
| Terbinafine Hcl | 78 | $2,124 |
| Amitriptyline Hcl | 40 | $424 |
| Allopurinol | 26 | $373 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $243 |
| Cephalexin | 48 | $195 |
| Ciprofloxacin Hcl | 15 | $188 |
| Methylprednisolone | 21 | $145 |
| Silver Sulfadiazine | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Memphis
- Walter ButlerMemphis$191K
- Clayton BettinMemphis$89K
- Tyler FraserMemphis$30K
- William HesterMemphis$20K
- Jesse TrentMemphis$12K
- Sebastien DemoinyMorristown$210K
- Robert ThompsonMurfreesboro$205K
- Bhekumuzi KhumaloUnion City$201K
- Chad WebsterCordova$185K
- Christian SmithCordova$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.